Danming He
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparative safety profiles of antibody-drug conjugates: a real-world analysis of monotherapy and combination regimens in solid tumors.
Journal: Drug delivery
Published: August 06, 2026
Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases.
Journal: Journal of the National Cancer Center
Published: July 07, 2025
Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.
Journal: Science China. Life sciences
Published: May 30, 2025
Lipocalin-2 drives brain metastatic progression through reciprocal tumor-microenvironment interactions in lung cancer.
Journal: Signal transduction and targeted therapy
Published: April 16, 2025
Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 11, 2025
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer.
Journal: Med (New York, N.Y.)
Published: December 14, 2023
Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer.
Journal: Frontiers in immunology
Published: July 24, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026